CHARACTERISTICS OF INFERTILE PATIENTS WITH OVULATORY DYSFUNCTION AND THEIR RELATION TO BODY MASS INDEX
AbstractBackground: Ovulatory dysfunction is a group of disorders with variable clinical presentationsoccasionally having serious long-term adverse effects. It accounts for 30% of female fertility problems.Evidence suggests an association between an individual’s weight and disorders of ovulation. Theobjective of our study was to describe the clinical and hormonal profile of subfertile women withovulatory dysfunction in relation to their body mass index (BMI). Methods: This prospective,descriptive study was carried out in Mother and Child Health Centre, PIMS, Islamabad and Railwayhospital, Rawalpindi from April 2001 to March 2007. One hundred & thirty eight infertile patients withovulatory dysfunction were included. The clinical data including BMI of each patient was recorded inaddition to reports of investigations comprised of cervical smear, pelvic ultrasound and hormonalprofile. Results: Primary infertility was found in 61% while secondary in 39% of the patients. Themean age was 29 years and mean duration of infertility was 6 years. Menstrual pattern was normal in56.5%. BMI was normal in 30.4% while most patients were overweight and obese. Prolonged cycles,history of systemic endocrine disorders, abnormal vaginal discharge, hirsutism, polycystic ovarianmorphology and hormonal abnormalities were more frequent in patients with increased BMI. Duringthe study period, 21.7% of the women conceived. Conclusion: Infertile patients with ovulatorydysfunction present more frequently with primary infertility. They usually have higher than requiredBMI. Oligomenorrhoea amenorrhoea, hirsutism and hormonal abnormalities are more frequent inoverweight than infertile patients with ovulatory dysfunction having a normal BMI.Keywords: Infertility, Ovulatory Dysfunction, Clinical Characteristics, Body mass index, BMI
Ismail M, Zaidi K. Infertility: causes and treatment at Sheikh
Zayed Hospital, Lahore. Mother Child 1998; 36(4):149–53.
McClure N, Thompson W. Investigation of the infertile couple.
In: Shaw RW, Soutter WP, Stanton SL, editors. Gynaecology.
Newyork: Churchill Livingstone, 1997;247–60.
Mehmood G, Sadia S. lnfertility data of Maternal & Child
Health Center, PIMS. J Surg 2001;21,22:10–3.
Sayeed U. Reproductive, demographic and behavioral causes
of infertility in India [abstract]. In: Malik MB, Alizadegan S,
editors. The 2nd Royan International Research Award:
Reproductive health and infertility, Sept 2001. Tehran:
Royan Institute, 2001: 18. [http://www.royaninstitute.org]
Kassi E, Diamanti-Kandarakis E. The effects of insulin
sensitizers on the cardiovascular risk factors in women with
polycystic ovary syndrome. J Endocrinol Invest
Aroda VR, Ciaraldi TP, Burke P, Mudaliar S, Clopton P,
Phillips S, et al. Metabolic and hormonal changes induced by
pioglitazone in polycystic ovary syndrome: a randomized,
placebo-controlled clinical trial. J Clin Endocrinol Metab
J Ayub Med Coll Abbottabad 2009;21(3)
Chang RJ. The reproductive phenotype in polycystic ovary
syndrome. Nat Clin Pract Endocrinol Metab 2007;3(10):688–95.
Chang RJ. Obesity and the emergence of sleep-wake
gonadotrophin secretion in girls during early pubertal
development. J Clin Endocrinol Metab 2009;94(4):1094–6.
Bordini B, Littlejohn E, Rosenfield RL Blunted sleep related
luteinizing hormone rise in healthy premenarcheal pubertal
girls with elevated body mass index. . J Clin Endocrinol
Rana S, Saeed S. Prevalence of infertility factors in Pakistan.
Pakistan J Obstet Gynaecol 1993;6(1):17–34.
Maheshwari A, Hamilton M, Bhattacharya S. Effect of
female age on the diagnostic categories of infertility. Hum
Usmani AT, Shaheen F, Waheed N. Laparoscopic evaluation
of female infertility. Pakistan Armed Forces Med J
Futterweit W. Polycystic ovary syndrome: a common
reproductive and metabolic disorder necessitating early
recognition and treatment. Prim Care 2007;34(4):761–89.
Waller K, Swan SH, Windham GC, Fenster L, Elkin EP,
Lesley BL. Use of urine biomarkers to evaluate menstrual
function in healthy premenopausal women. Am J Epidemiol
Shi Y, Guo M, Yan G, Sun W, Zhang X, Geng L, Xu L,
Chen Z. Analysis of clinical characteristics in large scale
Chinese women with polycystic ovary syndrome. Neuro
Endocrinol Lett 2007;28(6):807–10.
Barbieri RL. The initial fertility consultation:
recommendations concerning cigarette smoking, body mass
index and alcohol and caffeine consumption. Am J Obstet
Silfen ME, Denburg MR, Manibo AM, Lobo RA, Jeffe R,
Ferin M, Levine LS, Oberfield SE. Early endocrine,
metabolic and sonographic characteristics of polycystic ovary
syndrome (PCOS): comparison between nonobese and obese
adolescents. J Clin Endocrinol Metab 2003;88(10):4682–8.
Cupisti S, Kajaia N, Dittrich R, Duezenli H, Beckmann MW,
Mueller A. Body Mass Index and ovarian function are
associated with endocrine and metabolic abnormalities in
women with hyperandrogenic syndrome. Eur J Endocrinol
Liou TH, Yang JH, Hsieh CH, Lee CY, Hsu CS, Hsu MI.
Chemical and biochemical presentations of polycystic ovary
syndrome among obese and nonobese women. Fertil Steril
Nov 1. (Epub ahead of print).
Steeq JW, Sterues P, Eijkemans MJ, Habbema JD, Hompes
PJ, Broekmans FJ, et al. Predictive value and clinical impact
of basal follicle stimulating hormone in subfertile, ovulatory
women. J Clin Endocrinol Metab 2007;92(6):2163–8.
Tayyab M, Cheema YS, Khan H, Ditta A, Khan RL, Khan
AS. Serum levels of prolactin and female infertility. Pakistan
J Pathol 1999;10(2):12–4.